The effect of fecal microbiota transplantation on stroke outcomes: A systematic review

Amir Pasokh1, Mohammad Farzipour1, Javad Mahmoudi1

  • 1Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Abstract

Insights

Fecal microbiota transplantation (FMT) may offer a new therapeutic strategy for stroke. This approach, involving transferring gut microbes, shows potential in improving neurological outcomes and aiding recovery from stroke complications.

Area of Science:

  • Microbiology
  • Neurology
  • Gastroenterology

Background:

  • Fecal microbiota transplantation (FMT) is an emerging therapeutic strategy.
  • Its potential application in neurological disorders, including stroke, is under investigation.
  • This review assesses FMT's role in stroke progression, treatment, and post-stroke complication recovery.

Approach:

  • A systematic review of preclinical studies on FMT and stroke was conducted.
  • Searches were performed in major scientific databases (PubMed, Scopus, Cochrane, Google Scholar) up to February 2022.
  • Nineteen relevant publications were included from an initial pool of 4570 articles.

Key Points:

  • Transferring gut microbiota can influence key stroke indicators.
  • FMT impacts brain infarct volume and survival rates.
  • Neurological and behavioral outcomes, alongside inflammatory pathways, are affected by FMT.

Conclusions:

  • Manipulating gut microbiota through FMT presents a potential therapeutic avenue for stroke.
  • FMT may aid in the treatment of stroke.
  • This approach shows promise for the recovery of post-stroke complications.

Related Concept Videos